Biotech
Genta (GNTA) sank 25% after setting plans to sell 20 million shares in an bid to raise gross proceeds totaling $16 million.
The stock was dropping 28 cents to 82 cents early Wednesday. With only 30 minutes gone in the trading session, more than 15 million shares had already traded. The average volume for a full day is about 5.8 million shares. Genta said the closing should take place around Sept. 22. The shares are being sold under the company's registration statement declared effective by the Securities and Exchange Commission in May 2004 and the prospectus supplement dated Tuesday.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,435.57 | 1,315.89 | 2,830.09 | 15.81 |
Oil *
101.94
|
|
UP
15.71 |
UP
2.57 |
DOWN
7.27 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.81
|
|
+0.13%
|
+0.20%
|
-0.26%
|
-2.71%
|
Data delayed 20 minutes |
Connect with TheStreet